BackConstellation Pharmaceuticals Overview

Constellation Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CNST.

Quarterly EBIT

-$40.07M
↓ 63.03% YoY

As of Mar 31, 2021

Annual EBIT (TTM)

-$138.95M
↓ 56.72% YoY

Trailing 12 months ending Mar 31, 2021

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin